Finoriq research workspace
Azenta, Inc. (AZTA) SEC Filings & Filing Highlights
Azenta, Inc. provides biological and chemical compound sample exploration and management. Review AZTA SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
- Company
- Azenta, Inc. (AZTA)
- Ticker
- AZTA
- Market Cap
- $1.2B
- Latest Price
- $26.28
- Industry
- Industrial Machinery
Azenta, Inc. (AZTA) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Azenta, Inc. (AZTA).
| Event | Form | Date |
|---|---|---|
| Azenta, Inc.: Earnings or resultsOn May 5, 2026, Azenta, Inc. (“Azenta” or the “Company”) announced via press release its financial results for the fiscal quarter ended Mar... | 8-K2.02 | 2026-05-05 |
| On April 7, 2026, the Company issued a press release announcing the Multiomics segment leadersh...On April 7, 2026, the Company issued a press release announcing the Multiomics segment leadership transition. A copy of such press release... | 8-K7.01 | 2026-04-07 |
| On April 6, 2026, Ginger Zhou stepped down from her role as President of the Multiomics busines...On April 6, 2026, Ginger Zhou stepped down from her role as President of the Multiomics business of Azenta, Inc. (the “Company”). Dr. Zhou’... | 8-K5.02 | 2026-04-07 |
| /s/ Ephraim StarrAs previously disclosed in the Company’s Current Report on Form 8-K filed on December 29, 2025, Azenta Germany GmbH, a wholly owned subsidi... | 8-K8.01 | 2026-04-02 |
| On March 4, 2026, Azenta issued a press release announcing the entry into the Share Purchase Ag...On March 4, 2026, Azenta issued a press release announcing the entry into the Share Purchase Agreement discussed in Item 1.01 above. A copy... | 8-K7.01 | 2026-03-04 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.